These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2649158)

  • 1. Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
    Siris SG; Aronson A; Sellew AP
    Biol Psychiatry; 1989 Feb; 25(4):485-8. PubMed ID: 2649158
    [No Abstract]   [Full Text] [Related]  

  • 2. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
    Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):109-15. PubMed ID: 7905256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
    Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
    Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted treatment of depression-like symptoms in schizophrenia.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Fasano-Dube B
    Psychopharmacol Bull; 1987; 23(1):85-9. PubMed ID: 3602335
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression.
    Siris SG; Adan F; Strahan A; Aronson A; Mandeli J; Fasano-Dube B
    Compr Psychiatry; 1989; 30(6):483-8. PubMed ID: 2582754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
    Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia.
    Siris S; Pollack S; Bermanzohn P; Stronger R
    Schizophr Res; 2000 Sep; 44(3):187-92. PubMed ID: 10962221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of adjunctive imipramine in postpsychotic depression.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E
    Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903
    [No Abstract]   [Full Text] [Related]  

  • 14. Schizophrenia, panic attacks, and antidepressants.
    Yeragani VK; Balon R; Pohl R
    Am J Psychiatry; 1989 Feb; 146(2):279. PubMed ID: 2563213
    [No Abstract]   [Full Text] [Related]  

  • 15. Suicidal ideation in postpsychotic depression.
    Shuwall M; Siris SG
    Compr Psychiatry; 1994; 35(2):132-4. PubMed ID: 8187477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of panic disorder with imipramine alone.
    Garakani H; Zitrin CM; Klein DF
    Am J Psychiatry; 1984 Mar; 141(3):446-8. PubMed ID: 6367495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
    Evans L; Kenardy J; Schneider P; Hoey H
    Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
    Siris SG; Rifkin A; Reardon GT; November M
    Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.